|
(L1) 6501.1224-Atropine, Sulfate, 10 Mg/Ml (1%), Ophthalmic Solution, Drip Bottle, 5 Ml, Route Of Administration: Ophthalmic, Units. Size: Unit, (L1) 6501.1003-Timolol, Maleate, 5 Mg/Ml (0.5%), (L1) 6501.49543-Dexamethasone, 1Mg/Ml, Ophthalmic Suspension, Bottle, 5Ml, (L1) 6501.935-Pilocarpine, Hydrochloride, 20 Mg/Ml (2%), 10 Ml, (L1) 6501.31743-Moxifloxacin, Hydrochloride, 5 Mg/Ml, (L1) 6501.1004-Tobramycin + Dexamethasone, 3 Mg + 1 Mg/G, Ophthalmic Ointment, Tube, 3.5 G, (L2) 6501.229-Folinic Acid (Calcium Folinate), 15 Mg, Tablet, Blister, Route Of Administration: Oral, (L3) 6501.98941-Alteplase, 10Mg, Lyophilized Powder For Injection Solution, Ampoule Vial, Diluent, 10Ml, Route Of Administration: Intravenous, (L4) 6501.259-Aminophylline, 24 Mg/Ml, Injectable Solution, Ampoule, (L5) 6501.58228-Sodium Bicarbonate, Sodium Carbonate, Citric Acid, 2, 0, 5G, 2 G/5G, Oral Powder, Envelope, (L6) 6505.109191-Charcoal Activated, Oral, Powder, Powder, Primary Packaging: Sachet With 5 G., (L7) 6501.50119-Anhydrous Caffeine, 10Mg/Ml, Oral Solution, Packaging: Bottle, With 30Ml, (L8) 6501.520-Potassium Chloride, 60 Mg/Ml (6%), Oral Solution, 150 Ml, Dosing Cup/Syringe, (L9) 6501.48662-Cholecalciferol, 14,000Ui/Ml, (L10) 6502.5404-Tetracaine, Hydrochloride + Phenylephrine, 10 Mg/Ml (1%) + 1 Mg/Ml (0.1%), Ordinance 344/98: C1, (L11) 6501.48665-Desloratadine, Syrup, 100 Ml, (L12) 6501.37-Dipyrone Sodium, 500 Mg, (L13) 6501.4718-Erythromycin, Estolate, 50Mg/Ml, Oral Suspension, 50 Ml, % Accepted Variation (Up) In Primary Packaging Unit Of Measurement: 20, (L14) 6501.3756-Scopolamine, Butylbromide + Sodium Dipyrone, 6.7 Mg + 333.4 Mg/Ml, Drops Solution, 20Ml, (L15) 6501.1765-Scopolamine, Butylbromide, 20 Mg/Ml, 1 Ml, Route Of Administration: Subcutaneous/Intramuscular/Intravenous, (L16) 6501.3120-Fenoterol, Hydrobromide, 20 Ml, Route Of Administration: Oral/Inhalation, (L17) 6501.75320-Potassium Phosphate, 2 Meq/Ml, (L18) 6501.58460-Sodium Glycerophosphate, 216 Mg/Ml, (L19) 6501.1352-Sodium Heparin, 20,000 Iu/Ml (5,000 Iu/0.25Ml), 25 Ml, Route Of Administration: Subcutaneous, (L20) 6501.60729-Hydrocortisone, Acetate, 10 Mg/G, Dermatological Cream, 15 To 20 G, Route Of Administration: Dermatological, (L21) 6501.4756-Aluminum Hydroxide, 60 To 62 Mg/Ml, 100 To 150 Ml, (L22) 6501.795-Ibuprofen, 50 Mg/Ml, Suspension Drops, 30 Ml, (L23) 6501.3158-Nph Human Insulin, 100 Iu/Ml, Injectable Suspension, (L24) 6501.3160-Regular Human Insulin, (L25) 6501.838-Methylprednisolone, Sodium Succinate, 125 Mg, Powder For Injectable Solution, 2 Ml, Route Of Administration: Intramuscular/Intravenous, (L26) 6501.839-Methylprednisolone, 8 Ml, (L27) 6501.43094-Thiamazole, 10 Mg, (L28) 6505.97288-Neomycin, 250 Mg, Capsule, (L29) 6501.2506-Nimodipine, 30 Mg, Coated Tablet, (L30) 6501.1354-Octreotide, 1 Mg/Ml, Route Of Administration: Subcutaneous/Intravenous, (L31) 6501.1382-Oxymetazoline, 05%), Nasal Solution, Drip Bottle/Spray Bottle, Route Of Administration: Nasal, (L32) 6505.86610-Papain, 80 Mg/G (8%), Gel, Tube/Pot 60 G, Manipulated Product, Route Of Administration: Topical, (L33) 6505.76279-Papain, 100 Mg/G (10%), 20 G, (L34) 6505.86611-Papain, 60 Mg/G (6%), (L35) 6501.1398-Calcium Polystyrenesulfonate, 890/900 Mg/G, 30 G, (L36) 6501.2521-Polymyxin B, Sulfate + Neomycin, Sulfate + Hydrocortisone, 10,000 Iu + 5 Mg + 10 Mg/Ml, Otologic Suspension, Route Of Administration: Otologic, (L37) 6501.70303-Saccharomyces Boulardii, 200Mg, 1G, (L38) 6501.68460-Sacubitril Valsartan Sodium Hydrated, 50 Mg (
|
